Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HCV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02758509
What this trial is testing

Impact of Antiviral Therapy on Gastroesophageal Varices.

Who this might be right for
Chronic Hepatitis CCirrhosis
Parc de Salut Mar 237
Post-approval studies (Phase 4)Study completedNCT00189163
What this trial is testing

Pioglitazone in Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Michigan 40
Early research (Phase 1)Study completedNCT03430830
What this trial is testing

Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

Who this might be right for
Chronic Hepatitis c
Ascletis Pharmaceuticals Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT01995071
What this trial is testing

Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis
AbbVie 89
Post-approval studies (Phase 4)UnknownNCT02745132
What this trial is testing

Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)

Who this might be right for
Hepatitis C
Instituto de Investigación Marqués de Valdecilla 80
Testing effectiveness (Phase 2)Study completedNCT02278419
What this trial is testing

An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Janssen-Cilag International NV 63
Large-scale testing (Phase 3)Study completedNCT02170727
What this trial is testing

A Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 199
Post-approval studies (Phase 4)UnknownNCT03721627
What this trial is testing

Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease.

Who this might be right for
Gaucher DiseaseHCV
Mansoura University Children Hospital 10
Not applicableStudy completedNCT03053180
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

Who this might be right for
Chronic Hepatitis C
AbbVie 60
Not applicableStudy completedNCT01392742
What this trial is testing

An Observational Study on Predictive Factors of Response in Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 443
Post-approval studies (Phase 4)Study completedNCT00724620
What this trial is testing

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Schering-Plough 103
Early research (Phase 1)Study completedNCT01907724
What this trial is testing

Drug-Drug Interaction Between IDX719, Simeprevir, TMC647055 and Ritonavir When Administered in Combination in Healthy Participants (MK-1894-007)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 34
Testing effectiveness (Phase 2)Study completedNCT02868242
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 19
Not applicableStudy completedNCT00252642
What this trial is testing

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C

Who this might be right for
Hepatitis CCirrhosisFibrosis
Virginia Commonwealth University 60
Post-approval studies (Phase 4)Study completedNCT04457050
What this trial is testing

Effect of Hepatitis C Clearance on Insulin Resistance

Who this might be right for
Insulin ResistanceHepatitis C
Alexandria University 160
Early research (Phase 1)Active Not RecruitingNCT02772003
What this trial is testing

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic HepatitisHepatitis C InfectionHepatocellular Carcinoma
National Cancer Institute (NCI) 33
Large-scale testing (Phase 3)Study completedNCT01581203
What this trial is testing

Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 748
Not applicableStudy completedNCT04189627
What this trial is testing

The Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 99
Testing effectiveness (Phase 2)Study completedNCT01011166
What this trial is testing

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

Who this might be right for
Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC 81
Not applicableUnknownNCT02057003
What this trial is testing

Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients

Who this might be right for
Hepatitis C, ChronicHuman Immunodeficiency Virus
Valme University Hospital 1,000
Next Page